Arrayit Corporation (ARYC)

[MikeCr]

Yes, in the new OvaPlex Australian trial they are testing the addition of 2 more biomarkers to the original 5. They are trying to increase the "accuracy" to a min of 97%. Not sure if that refers to specificity or what. But to be a screening test you need close to 100% specificity (close to 0% false positives), not sure about the false negatives tolerance level (sensitivity)

Arrayit's OvaDx still seems much superior with its "100 biomarkers". I was wondering if even with FDA approval OvaDx will need peer review to confirm its results.

Also ASCO wants to weigh in about what biomarkers are used in tests (post # 866). They are supposed to issue guidelines in the future.